EFFECTIVENESS OF RADIOTHERAPY IN MYXOID SARCOMAS IS ASSOCIATED WITH A DENSE VASCULAR PATTERN

被引:50
作者
de Vreeze, Ronald S. A. [1 ]
de Jong, Daphne [2 ]
Haas, Rick L. [3 ]
Stewart, Fiona [4 ]
van Coevorden, Frits [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, NL-1066 CX Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Expt Therapy & Radiobiol, NL-1066 CX Amsterdam, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 05期
关键词
Sarcoma; Preoperative radiotherapy; Myxoid liposarcoma; Vascular;
D O I
10.1016/j.ijrobp.2008.03.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Surgery and adjuvant radiotherapy (RT) have long been the standard treatment for most deep-seated sarcomas; however, since the randomized trial from the National Cancer Institute of Canada, which described similar local control for pre- vs. postoperative RT, both modalities are now widely accepted. As a group, sarcomas are classified as radiation resistant. The subgroup of myxoid liposarcoma (MLS), a sarcoma with a typical vascular crow's feet pattern, is highly radiosensitive, but a mechanism for this phenomenon is unknown. Here we describe our results with preoperative RT and propose a mechanism explaining the high sensitivity based on the distinctive vascularization pattern of MLS. Methods and Materials: Between 2002 and 2006, 31 sarcoma patients, including 10 with MLS, underwent preoperative RT at our institute. Resected specimens were histologically evaluated, focusing on classification, grade, and vascularization patterns. Results: Twenty sarcomas showed more than 80% pathologic response after preoperative RT. A pathologic complete response was found in all "pure" MLS specimens after preoperative RT (n = 8). There were no pathologic complete responses in the remaining sarcoma patients (n = 23), although 12 showed 80% to 90% pathologic response. In contrast to the remaining RT-resistant sarcomas, the highly responding specimens contained branching vasculature, partial thrombus formation and inflammation of medium sized arterioles, similar to the vascular changes in MLS. Conclusions: Both MLS and sarcomas with MLS-like vasculature are highly radiosensitive. Radiation sensitivity may be explained by changes in medium-sized arterioles, obstructing the specific crow's feet vascularization and inducing hypoxia with secondary tumor cell death. (c) 2008 Elsevier Inc.
引用
收藏
页码:1480 / 1487
页数:8
相关论文
共 31 条
[1]   THE RESPONSE OF THE MICROVASCULAR SYSTEM TO RADIATION - A REVIEW [J].
BAKER, DG ;
KROCHAK, RJ .
CANCER INVESTIGATION, 1989, 7 (03) :287-294
[2]  
Chavaudra J, 1998, Cancer Radiother, V2, P607, DOI 10.1016/S1278-3218(98)80104-2
[3]  
Coindre JM, 2006, ARCH PATHOL LAB MED, V130, P1448
[4]   Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma [J].
Davis, AM ;
O'Sullivan, B ;
Turcotte, R ;
Bell, R ;
Catton, C ;
Chabot, P ;
Wunder, J ;
Hammond, A ;
Benk, V ;
Kandel, R ;
Goddard, K ;
Zee, B ;
Day, A ;
Tu, DS ;
Pater, J .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :48-53
[5]   LIPOSARCOMA - A RETROSPECTIVE STUDY OF 15 CASES A REVIEW OF LITERATURE AND A DISCUSSION OF RADIOSENSITIVITY [J].
EDLAND, RW .
AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1968, 103 (04) :778-&
[6]   Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology [J].
Engstrom, Katarina ;
Bergh, Peter ;
Cederlund, Claes-Goran ;
Hultborn, Ragnar ;
Willen, Helena ;
Aman, Pierre ;
Kindblom, Lars-Gunnar ;
Meis-Kindblom, Jeanne M. .
ACTA ONCOLOGICA, 2007, 46 (06) :838-845
[7]  
Fletcher CD, 2002, PATHOLOGY GENETICS T
[8]   IRRADIATION OF LIPOSARCOMA [J].
FRIEDMAN, M ;
EGAN, JW .
ACTA RADIOLOGICA, 1960, 54 (03) :225-239
[9]   Engaging the vascular component of the tumor response [J].
Fuks, Z ;
Kolesnick, R .
CANCER CELL, 2005, 8 (02) :89-91
[10]  
Hatano H, 2003, ANTICANCER RES, V23, P3045